Difference between revisions of "Professional organizations"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "http://www.siog.org/" to "https://siog.org/") |
||
(33 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | If you notice an organization that is not included please let us know or add it yourself! | + | <span id="BackToTop"></span> |
+ | <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px; opacity:0.8; border-style: solid; border-color:DarkGray; border-width: 1px"> | ||
+ | [[#top|Back to Top]] | ||
+ | </div> | ||
+ | If you notice an organization that is not included please let us know or add it yourself! We have a separate page for [[Study Groups|study groups.]] | ||
{| class="wikitable sortable" <!--border="1" style="text-align:left;" !align="left" --> | {| class="wikitable sortable" <!--border="1" style="text-align:left;" !align="left" --> | ||
− | ! | + | !Association |
− | ! | + | !Acronym |
− | ! | + | !Target Audience |
|- | |- | ||
|[http://www.aonnonline.org/ Academy of Oncology Nurse & Patient Navigators] | |[http://www.aonnonline.org/ Academy of Oncology Nurse & Patient Navigators] | ||
Line 25: | Line 29: | ||
|AACR | |AACR | ||
|General Cancer | |General Cancer | ||
+ | |- | ||
+ | |[https://www.americanbrachytherapy.org/ American Brachytherapy Society] | ||
+ | |ABS | ||
+ | |Radiation Oncology | ||
|- | |- | ||
|[http://www.cancer.org/ American Cancer Society] | |[http://www.cancer.org/ American Cancer Society] | ||
Line 62: | Line 70: | ||
|General Medicine | |General Medicine | ||
|- | |- | ||
− | |[ | + | |[https://www.americanradiumsociety.org/ American Radium Society] |
− | |ASBMT | + | |ARS |
+ | |Radiation Oncology | ||
+ | |- | ||
+ | |[https://www.astct.org/home American Society for Transplantation and Cellular Therapy] | ||
+ | |ASTCT (formerly ASBMT) | ||
|Transplant-specific | |Transplant-specific | ||
|- | |- | ||
Line 78: | Line 90: | ||
|Surgical Oncology | |Surgical Oncology | ||
|- | |- | ||
− | |[ | + | |[https://www.asco.org American Society of Clinical Oncology] |
|ASCO | |ASCO | ||
|General Cancer | |General Cancer | ||
Line 89: | Line 101: | ||
|ASH | |ASH | ||
|Hematology | |Hematology | ||
+ | |- | ||
+ | |[http://aspho.org/ American Society of Pediatric Hematology/Oncology] | ||
+ | |ASPHO | ||
+ | |Pediatric oncology | ||
|- | |- | ||
|[https://aspo.org/ American Society of Preventive Oncology] | |[https://aspo.org/ American Society of Preventive Oncology] | ||
Line 121: | Line 137: | ||
|API | |API | ||
|Pathology | |Pathology | ||
+ | |- | ||
+ | |[https://www.astro.org/Affiliate/ARRO Association of Residents in Radiation Oncology] | ||
+ | |ARRO | ||
+ | |Radiation Oncology | ||
|- | |- | ||
|[http://bahno.org.uk/ British Association of Head & Neck Oncologists] | |[http://bahno.org.uk/ British Association of Head & Neck Oncologists] | ||
Line 130: | Line 150: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[http://www.b-s-h.org.uk/ British Society | + | |[http://www.bsbmt.org/ British Society of Bone Marrow Transplantation] |
+ | |BSBMT | ||
+ | |Transplant-specific | ||
+ | |- | ||
+ | |[http://www.b-s-h.org.uk/ British Society for Haematology] | ||
|BSH | |BSH | ||
|Hematology | |Hematology | ||
Line 141: | Line 165: | ||
|CI4CC | |CI4CC | ||
|Informatics | |Informatics | ||
+ | |- | ||
+ | |Iberoamerican Coalition for Research in Breast Oncology (Coalición Iberoamericana De Investigación En Oncología) | ||
+ | |CIBOMA | ||
+ | |Histology-specific | ||
|- | |- | ||
|[https://www.cdc.gov/cancer/npcr/index.htm CDC National Program of Cancer Registries] | |[https://www.cdc.gov/cancer/npcr/index.htm CDC National Program of Cancer Registries] | ||
Line 173: | Line 201: | ||
|EAU | |EAU | ||
|Urologic Oncology | |Urologic Oncology | ||
+ | |- | ||
+ | |[https://www.enets.org/ European Neuroendocrine Tumor Society] | ||
+ | |ENETS | ||
+ | |Histology-specific | ||
|- | |- | ||
|[http://www.eortc.org/ European Organisation for Research and Treatment of Cancer] | |[http://www.eortc.org/ European Organisation for Research and Treatment of Cancer] | ||
Line 185: | Line 217: | ||
|EBMT | |EBMT | ||
|Transplant-specific | |Transplant-specific | ||
+ | |- | ||
+ | |[https://www.esp-pathology.org/ European Society of Pathology] | ||
+ | |ESP | ||
+ | |Pathology | ||
|- | |- | ||
|[http://www.eusoma.org/ European Society of Breast Cancer Specialists] | |[http://www.eusoma.org/ European Society of Breast Cancer Specialists] | ||
Line 206: | Line 242: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[http://www.esmo.org/ European Society for Medical Oncology] | + | |[https://www.genturis.eu/l=eng/Home.html European Reference Network for Genetic Tumour Risk Syndromes] |
+ | |GENTURIS | ||
+ | |Histology-specific | ||
+ | |- | ||
+ | |[https://paedcan.ern-net.eu European Reference Network for Paediatric Oncology] | ||
+ | |PaedCan | ||
+ | |Pediatric oncology | ||
+ | |- | ||
+ | |[https://euracan.eu European Reference Network for Rare Adult Solid Cancers] | ||
+ | |EURACAN | ||
+ | |Histology-specific | ||
+ | |- | ||
+ | |[http://www.esgo.org/ European Society of Gynaecological Oncology] | ||
+ | |ESGO | ||
+ | |Histology-specific | ||
+ | |- | ||
+ | |[https://www.esmo.org/ European Society for Medical Oncology] | ||
|ESMO | |ESMO | ||
|General Cancer | |General Cancer | ||
Line 228: | Line 280: | ||
|[http://www.uicc.org/german-cancer-society-0 German Cancer Society] | |[http://www.uicc.org/german-cancer-society-0 German Cancer Society] | ||
|GCS | |GCS | ||
+ | |General Cancer | ||
+ | |- | ||
+ | |[https://www.dgho.de German Society of Hematology and Medical Oncology (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie)] | ||
+ | |DGHO | ||
|General Cancer | |General Cancer | ||
|- | |- | ||
Line 237: | Line 293: | ||
|HPNA | |HPNA | ||
|Hospice | |Hospice | ||
+ | |- | ||
+ | |[https://www.ismpo.org/ Indian Society of Medical and Pediatric Oncology] | ||
+ | |ISMPO | ||
+ | |General Cancer | ||
|- | |- | ||
|[http://www.iom.edu/ Institute of Medicine of the National Academies] | |[http://www.iom.edu/ Institute of Medicine of the National Academies] | ||
|IOM | |IOM | ||
|General Medicine | |General Medicine | ||
+ | |- | ||
+ | |[http://www.iacr.com.fr/index.php International Association of Cancer Registries] | ||
+ | |IACR | ||
+ | |Cancer Registry | ||
|- | |- | ||
|[https://www.iaslc.org/ International Association for the Study of Lung Cancer] | |[https://www.iaslc.org/ International Association for the Study of Lung Cancer] | ||
Line 258: | Line 322: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[ | + | |[https://igcs.org/ International Gynecologic Cancer Society] |
− | | | + | |IGCS |
+ | |Histology-specific | ||
+ | |- | ||
+ | |[https://www.myeloma.org/ International Myeloma Foundation] | ||
+ | |IMF | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
Line 266: | Line 334: | ||
|General Cancer | |General Cancer | ||
|- | |- | ||
− | |[http://www.siog.org/ International Society of Geriatric Oncology] | + | |[https://melanoma-inc.org/ International Neoadjuvant Melanoma Consortium] |
+ | |INMC | ||
+ | |Histology-specific | ||
+ | |- | ||
+ | |[http://www.amyloidosis.nl/ International Society of Amyloidosis] | ||
+ | |ISA | ||
+ | |Histology-specific | ||
+ | |- | ||
+ | |[https://siog.org/ International Society of Geriatric Oncology] | ||
|SIOG | |SIOG | ||
|General Cancer | |General Cancer | ||
Line 272: | Line 348: | ||
|[http://www.irpa.net/page.asp?id=54507 International Society for Radiation Oncology] | |[http://www.irpa.net/page.asp?id=54507 International Society for Radiation Oncology] | ||
|ISRO | |ISRO | ||
+ | |Radiation Oncology | ||
+ | |- | ||
+ | |[https://isrsy.org/ International Society of Stereotactic Radiosurgery] | ||
+ | |ISRS | ||
|Radiation Oncology | |Radiation Oncology | ||
|- | |- | ||
Line 301: | Line 381: | ||
|KCA | |KCA | ||
|Histology-specific | |Histology-specific | ||
+ | |- | ||
+ | |[http://eng.ksmo.or.kr/main.html Korean Society of Medical Oncology] | ||
+ | |KSMO | ||
+ | |General cancer | ||
+ | |- | ||
+ | |[https://lacogcancerresearch.org Latin American Cooperative Oncology Group] | ||
+ | |LACOG | ||
+ | |General cancer | ||
|- | |- | ||
|[http://www.lls.org/ Leukemia & Lymphoma Society] | |[http://www.lls.org/ Leukemia & Lymphoma Society] | ||
|LLS | |LLS | ||
|Hematology | |Hematology | ||
+ | |- | ||
+ | |[https://mymos.my/ Malaysian Oncological Society] | ||
+ | |MOS | ||
+ | |General cancer | ||
|- | |- | ||
|[http://www.themmrf.org/ Multiple Myeloma Research Foundation] | |[http://www.themmrf.org/ Multiple Myeloma Research Foundation] | ||
Line 314: | Line 406: | ||
|Hematology | |Hematology | ||
|- | |- | ||
− | |[ | + | |[https://www.cancer.gov/ National Cancer Institute] |
|NCI | |NCI | ||
|General Cancer | |General Cancer | ||
Line 325: | Line 417: | ||
|NCCS | |NCCS | ||
|Survivorship | |Survivorship | ||
+ | |- | ||
+ | |[https://www.ncoda.org/ National Community Oncology Dispensing Association] | ||
+ | |NCODA | ||
+ | |Pharmacy | ||
|- | |- | ||
|[http://www.nccn.org/ National Comprehensive Cancer Network] | |[http://www.nccn.org/ National Comprehensive Cancer Network] | ||
Line 345: | Line 441: | ||
|NAACCR | |NAACCR | ||
|Cancer Registry | |Cancer Registry | ||
+ | |- | ||
+ | |[https://nanets.net North American Neuroendocrine Tumor Society] | ||
+ | |NANETS | ||
+ | |Histology-specific | ||
|- | |- | ||
|[https://www.ons.org/ Oncology Nursing Society] | |[https://www.ons.org/ Oncology Nursing Society] | ||
Line 372: | Line 472: | ||
|[http://siop-online.org/ International Society of Pediatric Oncology] | |[http://siop-online.org/ International Society of Pediatric Oncology] | ||
|SIOP | |SIOP | ||
− | | | + | |Pediatric oncology |
|- | |- | ||
|[https://www.sitcancer.org/home Society for Immunotherapy of Cancer] | |[https://www.sitcancer.org/home Society for Immunotherapy of Cancer] | ||
|SITC | |SITC | ||
|Treatment-specific | |Treatment-specific | ||
+ | |- | ||
+ | |[https://integrativeonc.org/ Society for Integrative Oncology] | ||
+ | |SIO | ||
+ | |Supportive oncology | ||
|- | |- | ||
|[http://www.soc-neuro-onc.org/ Society for NeuroOncology] | |[http://www.soc-neuro-onc.org/ Society for NeuroOncology] | ||
Line 393: | Line 497: | ||
|SSO | |SSO | ||
|Surgical Oncology | |Surgical Oncology | ||
+ | |- | ||
+ | |[https://www.singaporeoncology.org.sg/ Singapore Society of Oncology] | ||
+ | |SSO | ||
+ | |General Cancer | ||
|- | |- | ||
|[http://suonet.org/ Society of Urologic Oncology] | |[http://suonet.org/ Society of Urologic Oncology] | ||
Line 401: | Line 509: | ||
|RANZCR | |RANZCR | ||
|Radiology | |Radiology | ||
+ | |- | ||
+ | |[http://www.taiwanoncologysociety.org.tw/ehc-tos/s/index.htm Taiwan Oncology Society] | ||
+ | |TOS | ||
+ | |General cancer | ||
|- | |- | ||
|[http://www.ukmf.org.uk/ UK Myeloma Forum] | |[http://www.ukmf.org.uk/ UK Myeloma Forum] |
Latest revision as of 17:31, 28 June 2024
If you notice an organization that is not included please let us know or add it yourself! We have a separate page for study groups.